Looking for more Scientific Resources

The William Guy Forbeck Research Foundation is working with the scientific community to shortening the cancer research timetable.

2015 Newsletter – Invasion & Metastasis

July 22, 2015

2014 – Invasion and Metastasis November 6th – 9th Ann Chambers, PhD                              Zena Werb, PhD University of Western Ontario                University of California London, ON Canada                              San Francisco, CA Most cancer deaths are due to metastasis – the spread of cancer from its site of origin to distant, vital organs, and the physiological damage caused by tumor growth

2014 Newsletter – Resistance Mechanisms

November 19, 2014

CHAIRMEN Joan Brugge, Ph.D. Harvard Medical School Boston, MA Jeffrey Engelman MD, Ph.D. Massachusetts General Hospital Boston, MA OVERVIEW Cancer therapies that specifically target the genetic alterations associated with subsets of advanced cancers have shown impressive success in the clinic.  Examples include ABL inhibitors fro chronic myelogenous leukemia, RAF inhibitors for BRAF mutant melanomas, EGFR

2013 Newsletter- Tumour Metabolism

March 7, 2013

CHAIRMEN   Lewis C. Cantley, PhD                                          Beth Israel Deaconess Medical Center Boston, MA   Eileen White, PhD                                                  The Cancer Institute of New Jersey New Brunswick, NJ   OVERVIEW   Oncogenic events that convert normal cells into cancer cells promote cell growth and proliferation and inactivate checkpoints that would normally block these functions in the absence

2012 Newsletter- Epigenetics

March 18, 2012

CHAIRMEN Scott Armstrong, MD, PhD Children’s Hospital, Harvard Medical School Boston, MA   Steven Henikoff, PhD                                            Fred Hutchinson Cancer Research Center Howard Hughes Medical Institute Seattle, WA   OVERVIEW Cancer development is a multi-step process with mutations in proto-oncogenes and tumor suppressor genes playing a well-defined role.  In this regard, cancer is a genetic disease.

2011 Newsletter- Cancer Genomics

March 18, 2011

This edition of the Forbeck Newsletter includes the 2010 Forum Summary on Cancer Genomics, as well as information about the 2011 on Epigenetics and Drugy Therapy and 2012 Tumor Metabolism Forums.  There is also an update from the INRG (International Neuroblastoma Research Group.) Chairmen: Richard Kolodner, PhD; Prof. Michael R. Stratton, FRCPath     I:  Molecular